Avalo Therapeutics, Inc. (AVTX)
NASDAQ·Healthcare·Biotechnology
$18.91
-3.13%
Mkt Cap $212.56M
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (11 analysts)
$47.14
Range $34.00 – $60.00
Implied Upside
+149.3%
Consensus $47.14 vs current $18.91
NASDAQ·Healthcare·Biotechnology
$18.91
-3.13%
Mkt Cap $212.56M
Buy
10
Hold
0
Sell
0
Price Target (11 analysts)
$47.14
Range $34.00 – $60.00
+149.3%
Consensus $47.14 vs current $18.91